Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment

被引:5
|
作者
Heidenreich, Sebastian [1 ]
Rutten, Lila J. Finney [2 ]
Miller-Wilson, Lesley-Ann [3 ]
Jimenez-Moreno, Cecilia [1 ]
Chua, Gin Nie [1 ]
Fisher, Deborah A. [4 ]
机构
[1] Evidera, London, England
[2] Mayo Clin, Div Epidemiol, Dept Quantitat Hlth Sci, Rochester, MN USA
[3] Exact Sci Corp, 5505 Endeavor Lane, Madison, WI 53719 USA
[4] Duke Clin Res Inst, Durham, NC USA
来源
CANCER MEDICINE | 2022年 / 11卷 / 16期
关键词
colonoscopy; colorectal cancer; colorectal neoplasms; early detection of cancer; patient preference; physicians; screening; COMPETING STRATEGIES; HEALTH IMPACT; TASK-FORCE; ADHERENCE; SERVICES; ADULTS; TESTS;
D O I
10.1002/cam4.4678
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Guidelines include several options for average-risk colorectal cancer (CRC) screening that vary in aspects such as invasiveness, recommended frequency, and precision. Thus, patient and provider preferences can help identify an appropriate screening strategy. This study elicited CRC screening preferences of physicians and individuals at average risk for CRC (IAR). Methods IAR aged 45-75 years and licensed physicians (primary care or gastroenterology) completed an online discrete choice experiment (DCE). Participants were recruited from representative access panels in the US. Within the DCE, participants traded off preferences between screening type, screening frequency, true-positive, true-negative, and adenoma true positive (physicians only). A mixed logit model was used to obtain predicted choice probabilities for colonoscopy, multi-target stool DNA (mt-sDNA), fecal immunochemical test (FIT), and methylated septin 9 (mSEPT9) blood test. Results Preferences of IAR and physicians were affected by screening precision and screening type. IAR also valued more regular screening. Physicians preferred colonoscopy (96.8%) over mt-sDNA (2.8%; p < 0.001), FIT (0.3%; p < 0.001) and mSEPT9 blood test (0.1%; p < 0.01). IAR preferred mt-sDNA (38.8%) over colonoscopy (32.5%; p < 0.001), FIT (19.2%; p < 0.001), and mSEPT9 blood test (9.4%; p < 0.001). IAR naive to screening preferred non-invasive screening (p < 0.001), while the opposite was found for those who previously underwent colonoscopy or sigmoidoscopy. Conclusions While physicians overwhelmingly preferred colonoscopy, preferences of IAR were heterogenous, with mt-sDNA being most frequently preferred on average. Offering choices in addition to colonoscopy could improve CRC screening uptake among IAR. This study used a discrete choice experiment in the US to elicit preferences of physicians and individuals at average risk for colorectal cancer screening modalities and their characteristics.
引用
收藏
页码:3156 / 3167
页数:12
相关论文
共 50 条
  • [1] Preferences for colorectal cancer screening of physicians and individuals at average risk in the United States: A discrete choice experiment
    Heidenreich, Sebastian
    Rutten, Lila J. Finney
    Miller-Wilson, Lesley-Ann
    Moreno-Jimenez, Cecilia
    Chua, Gin Nie
    Fisher, Deborah
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [2] Preferences for Colorectal Cancer Screening of Physicians and Individuals at Average Risk in the United States: A Discrete Choice Experiment
    Heidenreich, Sebastian
    Rutten, Lila J. Finney
    Miller-Wilson, Lesley-Ann
    Moreno-Jimenez, Cecilia
    Chua, Gin Nie
    Fisher, Deborah A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1338 - S1339
  • [3] What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment
    van Dam, L.
    Hol, L.
    de Bekker-Grob, E. W.
    Steyerberg, E. W.
    Kuipers, E. J.
    Habbema, J. D. F.
    Essink-Bot, M. L.
    van Leerdam, M. E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2010, 46 (01) : 150 - 159
  • [4] What Determines Individuals' Preferences for Colorectal Cancer Screening Tests? a Discrete Choice Experiment
    Hol, Lieke
    van Dam, Leonie
    de Bekker-Grob, Esther W.
    Steyerberg, Ewout W.
    Kuipers, Ernst J.
    Habbema, J. D.
    Essink-Bot, Marie Louise
    van Leerdam, Monique
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A766 - A766
  • [5] Individuals' Preferences for Esophageal Cancer Screening: A Discrete Choice Experiment
    Peters, Yonne
    van Grinsven, Evi
    van de Haterd, Michelle
    van Lankveld, Daan
    Verbakel, Juul
    Siersema, Peter D.
    [J]. VALUE IN HEALTH, 2020, 23 (08) : 1087 - 1095
  • [6] Preferences for colorectal cancer screening strategies: a discrete choice experiment
    L Hol
    E W de Bekker-Grob
    L van Dam
    B Donkers
    E J Kuipers
    J D F Habbema
    E W Steyerberg
    M E van Leerdam
    M L Essink-Bot
    [J]. British Journal of Cancer, 2010, 102 : 972 - 980
  • [7] Preferences for colorectal cancer screening strategies: a discrete choice experiment
    Hol, L.
    de Bekker-Grob, E. W.
    van Dam, L.
    Donkers, B.
    Kuipers, E. J.
    Habbema, J. D. F.
    Steyerberg, E. W.
    van Leerdam, M. E.
    Essink-Bot, M. L.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (06) : 972 - 980
  • [8] INDIVIDUALS' PREFERENCES FOR ESOPHAGEAL CANCER SCREENING STRATEGIES - A DISCRETE CHOICE EXPERIMENT
    Peters, Yonne
    van Grinsven, Evi
    van de Haterd, Michelle
    van Lankveld, Daan
    Verbakel, Juul
    Siersema, Peter D.
    [J]. GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB468 - AB468
  • [9] Stated preferences for colorectal cancer screening using a discrete choice experiment
    Kromm, Seija K.
    Heitman, Steven J.
    Hilsden, Robert J.
    Marshall, Deborah A.
    McGregor, S. Elizabeth
    Currie, Gillian R.
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A80 - A80
  • [10] PUBLIC PREFERENCES FOR GENETIC SCREENING FOR COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT
    Veldwijk, J.
    Lambooij, M. S.
    Bredenoord, A.
    van Kranen, H.
    Dekker, E.
    Kallenberg, F.
    Smit, H. A.
    de Wit, G. A.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A647 - A647